AirDuo RespiClick (Fluticasone/Salmeterol)

Overview
AirDuo RespiClick is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma in people age 12 years and older. AirDuo RespiClick may be prescribed off-label in cases of chronic… read more

Alvesco (Ciclesonide)

Overview
Alvesco is a prescription drug approved by the Food and Drug Administration (FDA) in 2008 for maintenance treatment of asthma in people 12 years of age and older. In chronic obstructive pulmonary disease… read more

Anoro Ellipta (Umeclidinium/Vilanterol)

Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more

Aralast NP (Alpha1-proteinase inhibitor [human])

Overview
Aralast NP is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Arcapta Neohaler (Indacaterol maleate)

Overview

Arcapta is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 for maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD). Arcapta is not… read more

Arnuity Ellipta (Fluticasone furoate)

Overview

Arnuity Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Arnuity Ellipta is not… read more

Atrovent (Ipratropium bromide)

Overview
Atrovent is a prescription drug approved by the Food and Drug Administration (FDA) for the maintenance treatment of bronchospasms caused by asthma, allergies, chronic obstructive pulmonary disease (COPD), and… read more

Bevespi Aerosphere (Glycopyrrolate/Formoterol fumarate)

Overview
Bevespi Aerosphere is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Breo Ellipta (Fluticasone/Vilanterol)

Overview

Breo Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2013 for daily maintenance treatment in cases of chronic obstructive pulmonary disease (COPD). Breo Ellipta helps… read more

Breztri (Budesonide, Glycopyrrolate, and Formoterol fumarate)

Overview
Breztri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as long-term, daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Brovana (Arformoterol)

Overview

Brovana is a prescription drug first approved by the Food and Drug Administration (FDA) for long-term maintenance of bronchoconstriction in chronic obstructive pulmonary disease (COPD). Brovana is not… read more

Bullectomy

Overview

In people with chronic obstructive pulmonary disease (COPD), the structure of the lung weakens. The alveoli, tiny sacs of air where carbon dioxide is exchanged for oxygen, may become damaged. If the alveoli… read more

Combivent Respimat (Ipratropium bromide/Albuterol)

Overview
Combivent Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Combivent Respimat is… read more

Daliresp (Roflumilast)

Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a… read more

Duaklir Pressair (Aclidinium bromide/Formoterol fumarate)

Overview
Duaklir Pressair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

DuoNeb (Ipratropium/Albuterol)

Overview
DuoNeb is a prescription drug approved by the Food and Drug Administration (FDA) to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD) who need more than one bronchodilator. DuoNeb… read more

Dupixent (Dupilumab)

Overview
Dupixent is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (high levels…

Elixophyllin (Theophylline)

Overview
Elixophyllin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and…

Fasenra (Benralizumab)

Overview
Fasenra is a prescription medication approved by the Food and Drug Administration (FDA) to treat severe asthma in people age 12 and older. Fasenra may be prescribed in cases of asthma that test positive for an… read more

Foradil (Formoterol) for COPD

The Foradil brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Glassia (Alpha1-proteinase inhibitor [human])

Overview
Glassia is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin deficiency, a rare genetic… read more

Incruse Ellipta (Umeclidinium bromide)

Overview
Incruse Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary… read more

Lonhala Magnair (Glycopyrrolate)

Overview
Lonhala Magnair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD).… read more

Lung transplant

Overview
Lung transplant may be an option for some people with end-stage chronic obstructive pulmonary disease (COPD) who have tried every other avenue of treatment. Lung transplants may involve one (single-lung… read more

Lung volume reduction surgery

Overview

Lung volume reduction surgery is an option for some people with severe, advanced emphysema, a type of chronic obstructive pulmonary disease (COPD). In these people, the lungs are hyperinflated and cannot… read more

Nebulizer

Overview

Nebulizers are small devices sometimes used to deliver medications directly into the lungs in people with chronic obstructive pulmonary disease (COPD). Nebulizers can be used with a wide variety of… read more

Nucala (Mepolizumab)

Overview
Nucala is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (a type of…

Ohtuvayre (Ensifentrine)

Overview
Ohtuvayre is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It is prescribed to help manage symptoms and improve…

Oral or intravenous steroids

Overview
Corticosteroids (also referred to as steroids) are prescription medications used to control inflammation in people with chronic obstructive pulmonary disease (COPD). Some COPD maintenance medications contain… read more

Oxygen therapy

Overview

People with severe cases of chronic obstructive pulmonary disease (COPD) may develop hypoxia, or low levels of oxygen in the blood. Breathlessness is not necessarily a sign of hypoxia. Hypoxia can only be… read more

Perforomist (Formoterol)

Overview
Perforomist is a prescription drug first approved by the Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD).… read more

Prednisone

Overview

Prednisone is a prescription medication originally approved by the Food and Drug Administration (FDA). Prednisone is used to treat many conditions including allergies, Crohn’s disease, and chronic obstructive… read more

ProAir (Albuterol) for COPD

The ProAir brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more

Prolastin-C (Alpha1-proteinase inhibitor [human])

Overview
Prolastin-C is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Pulmicort (Budesonide)

Overview
Pulmicort is a prescription drug approved by the Food and Drug Administration (FDA) for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Pulmicort is not indicated for rescue…

Rayos (Prednisone)

Overview
Rayos is a prescription drug approved by the Food and Drug Administration (FDA) to treat acute exacerbations of chronic obstructive pulmonary disease (COPD). Rayos is also known by its drug name, Prednisone.… read more

Seebri Neohaler (Glycopyrrolate) for COPD

The Seebri Neohaler brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk… read more

Serevent Diskus (Salmeterol)

Overview
Serevent is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma and prevent bronchospasms in people age 4 and older with reversible obstructive airway problems such as chronic… read more

Spiriva (Tiotropium bromide)

Overview
Spiriva is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of bronchospasms in people with chronic obstructive pulmonary disease (COPD),… read more

Stiolto Respimat (Tiotropium bromide/Olodaterol)

Overview
Stiolto Respimat is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more

Striverdi Respimat (Olodaterol)

Overview

Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat… read more

Symbicort (Budesonide/Formoterol)

Overview
Symbicort is a prescription drug approved by the Food and Drug Administration (FDA) in 2006 for the treatment of asthma and 2009 for chronic obstructive pulmonary disease (COPD). Symbicort helps prevent… read more

Theo-24 (Theophylline)

Overview

Theo-24 is a prescription drug approved by the Food and Drug Administration (FDA) in 1983 to treat the symptoms of reversible airflow diseases such as asthma and chronic bronchitis. In severe cases of chronic… read more

Trelegy (Fluticasone furoate/Umeclidinium/Vilanterol)

Overview
Trelegy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for daily maintenance treatment of chronic obstructive pulmonary disease (COPD). Trelegy helps prevent bronchospasms.… read more

Tudorza (Aclidinium bromide)

Overview
Tudorza is a prescription drug approved by the Food and Drug Administration (FDA) for maintenance treatment of bronchospasm in chronic obstructive pulmonary disease (COPD). Tudorza is not indicated for rescue… read more

Utibron Neohaler (Indacaterol/Glycopyrrolate)

Overview
Utibron Neohaler is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD).… read more

Xolair (Omalizumab)

Overview
Xolair is a prescription medication approved by the Food and Drug Administration (FDA) approved for use in people age 6 and older with moderate to severe asthma that is not controlled adequately with an inhaled… read more

Xopenex (Levalbuterol)

Overview
Xopenex is a prescription drug approved by the Food and Drug Administration (FDA) to prevent and treat bronchospasms in diseases such as asthma and chronic obstructive pulmonary disease (COPD). Xopenex is also… read more

Yupelri (Revefenacin)

Overview
Yupelri is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is prescribed to help manage symptoms of COPD on a daily basis…

Zemaira (Alpha1-proteinase inhibitor [human])

Overview
Zemaira is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Zephyr Valve insertion surgery

Overview

Zephyr Valve insertion surgery is an option approved by the U.S. Food and Drug Administration (FDA) for some people with severe, advanced emphysema — a type of chronic obstructive pulmonary disease (COPD). In… read more